Acadia Pharmaceuticals Inc: Form 8-K, filed May 1, 2026
Filed with the SEC on May 1, 2026 and accepted by EDGAR at Apr 30, 2026, 17:34 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-197957. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.